Wild Yam Cream for Menopause: Why Diosgenin Doesn't Become Progesterone in Humans

Wild yam (Dioscorea villosa) cream and capsules are sold to perimenopausal and menopausal women as "natural progesterone," premised on the idea that the plant steroid diosgenin will be converted by the body into bioidentical progesterone. This is one of the most persistent supplement claims that fundamentally misunderstands a chemistry. Diosgenin is a precursor for the industrial synthesis of progesterone, but human metabolism cannot perform the required ring modifications.

The industrial chemistry origin

In the 1940s the chemist Russell Marker developed a synthetic route from diosgenin extracted from Mexican wild yams to progesterone, dramatically lowering the cost of progesterone and oral contraceptives. The conversion required harsh chemical steps including degradation of the spiroketal side chain, dehydration, and reduction with reagents not present in any tissue. The Marker synthesis is industrial chemistry. Human enzymes neither catalyze this transformation nor have substrate specificity for diosgenin in steroid biosynthesis pathways [1].

Direct human evidence: no progesterone effect

Komesaroff and colleagues 2001 conducted a placebo-controlled crossover RCT in 23 healthy postmenopausal women using wild yam cream for three months. Salivary and serum estradiol, progesterone, FSH, LH, lipids, weight, and menopausal symptom scores showed no difference between cream and placebo [2]. The investigators specifically looked for evidence of progesterone elevation and found none. This finding has been replicated in smaller observational studies.

Where "wild yam cream" really gets its progesterone

Some products labeled "wild yam cream" are spiked with bioidentical progesterone manufactured separately. In these cases any clinical effect comes from the added progesterone, not the yam extract. This crossover has caused regulatory action because the products are then either unapproved drugs (if progesterone is added without labeling) or mislabeled supplements. Consumers who believe they are using a plant-only product may be receiving variable doses of pharmacologic progesterone with associated risks. The 2013 FDA enforcement action against several manufacturers documented spiked products under the "wild yam" label [3].

The DHEA confusion

Some marketing claims state that diosgenin converts to DHEA or pregnenolone. This too is incorrect. DHEA is synthesized from cholesterol via pregnenolone and 17-hydroxypregnenolone, with no enzymatic route from diosgenin. Capsules sold as "DHEA precursor" via diosgenin do not raise serum DHEA. DHEA itself is a regulated substance in some jurisdictions and has its own evidence base (see DHEA articles).

Symptomatic effects unrelated to progesterone

Some users report symptomatic improvement, which is consistent with the substantial placebo response in vasomotor symptom trials (typically 30 to 50 percent reduction in hot flush frequency on placebo). Wild yam itself contains saponins and other compounds with possible mild anti-inflammatory or estrogenic activity, but no demonstrated effect on the relevant menopausal endpoints. Symptomatic relief should not be misread as hormonal effect.

What actually works for menopause symptoms

Evidence-based options for moderate-to-severe vasomotor symptoms include menopausal hormone therapy under medical supervision, the NK3 receptor antagonist fezolinetant, SSRIs/SNRIs in selected patients, and cognitive behavioral therapy. Among supplements, soy isoflavones in East Asian populations and black cohosh have evidence bases that are imperfect but exist. Wild yam cream sold as "natural progesterone" does not belong in this conversation. Patients seeking actual progesterone should obtain it through bioidentical hormone prescribing from a licensed clinician, where dose, route, and indication are appropriately documented.